Back to Journals » Neuropsychiatric Disease and Treatment » Volume 22
Traditional Chinese Medicine Ameliorates Depression via the Gut-Brain Axis: A Review Focus on NLRP3/TLR4-Mediated Inflammatory Pathways and Gut Microbiota Modulation
Authors Che L, Xie J, Xia C, Yu Q
Received 6 November 2025
Accepted for publication 28 December 2025
Published 8 January 2026 Volume 2026:22 579710
DOI https://doi.org/10.2147/NDT.S579710
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Taro Kishi
Longfei Che,1 Jiaming Xie,2 Chunlei Xia,1 Qinming Yu3
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China; 2Yangsheng College of Traditional Chinese Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550025, People’s Republic of China; 3School of Humanities and Management, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China
Correspondence: Qinming Yu, School of Humanities and Management, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People’s Republic of China, Tel +86151-4642-3222, Email [email protected]
Objective: Depression, a global mental disorder, is linked to gut-brain axis (GBA) dysfunction. This review explores how traditional Chinese medicine (TCM)—including single herbs (eg, Astragalus membranaceus, Lycium barbarum), herbal formulas (eg, Xiaoyaosan, Xiaochaihu Decoction), and acupuncture—alleviates depression via the GBA, focusing on neuroscience-relevant mechanisms (inflammation, neurotrophy).
Methods: A systematic literature search was conducted on PubMed, China National Knowledge Infrastructure (CNKI), and Embase from database inception to July 2025. Keywords included [“Traditional Chinese Medicine” or “TCM” or “herb” or “herbal extracts” or “Chinese herbal formulas”], [“depression” or “Depressive like behavior”], [“immune regulation”], [“inflammatory reaction”], [“neuroregeneration” or “nerve” or “neurotransmitter”]. Including peer-reviewed studies on human/animal models, articles that do not meet the requirements are excluded. A total of 307 eligible studies were included.
Results: TCM regulates gut microbiota composition—eg, increasing Lactobacillus and Bifidobacterium while reducing pathogenic taxa. Mechanistically, TCM inhibits pro-inflammatory pathways: herbs (eg, Astragalus membranaceus) and formulas (eg, Xiaoyaosan) downregulate IL-6, TNF-α, and IL-1β via suppressing NLRP3 inflammasome and TLR4/NF-κB signaling. They also enhance anti-inflammatory IL-10, elevate neurotransmitters (5-HT, DA), and upregulate BDNF. Acupuncture mirrors these effects, reducing plasma IL-6/TNF-α and restoring microbial balance to improve depressive behaviors.
Conclusion: TCM alleviates depression by integrating gut microbiota modulation, inflammatory suppression, and neuroprotection through the GBA. This review highlights TCM’s potential as a safe, alternative therapy for depression and identifies directions for standardized, large-scale clinical validation.
Keywords: traditional chinese medicine, Depression, gut microbiota, gut-brain axis, inflammatory reaction, immune regulation, neuroregeneration
Introduction
The Gut-Brain Axis (GBA) refers to a bidirectional communication network between the gut microbiota and the central nervous system, which has gradually gained attention in the research of psychological disorders such as depression.1 Depression is a global mental health crisis: the World Health Organization (WHO) estimates it affects 280 million people worldwide (3.8% of the global population), with 5% of adults suffering from major depressive disorder (MDD).2,3 It is the leading cause of disability globally, imposing substantial economic burdens (exceeding $2 trillion annually) and increasing the risk of suicide—accounting for over 700,000 deaths each year.4,5 Its pathological mechanism is complex, involving genetics, environment, neuroinflammation, and neurotransmitter imbalance, with GBA dysfunction emerging as a key contributor.6
Conventional treatments for depression primarily rely on pharmacotherapy (eg, selective serotonin reuptake inhibitors, SSRIs) and psychotherapy (eg, cognitive-behavioral therapy, CBT). However, these approaches have notable limitations: SSRIs often cause side effects (gastrointestinal distress, sexual dysfunction, weight gain) that lead to 30–50% of patients discontinuing treatment;7 approximately 30% of MDD patients are refractory to first-line drugs.8 Psychotherapy, while effective, is limited by high costs, poor accessibility in low- and middle-income countries, and reliance on trained professionals. Thus, there is an urgent need to explore safe, accessible alternative therapies.
In traditional Chinese medicine (TCM) theory, intestinal health is regarded as an important component of overall health.9 TCM aims to improve the intestinal environment by regulating visceral functions and balancing yin and yang (A core TCM theory describing two opposing yet complementary forces that maintain bodily homeostasis; TCM treats depression by balancing yin-yang)., thereby influencing mental health.10 In recent years, a growing number of studies have begun to explore the role of TCM in regulating the gut microbiota, especially in the treatment of depression.11–13 Zhi-Zi-Chi decoction, a TCM formula consisting of Gardenia jasminoides and fermented soybean, with effects of clearing heat and relieving restlessness. Studies have shown that Zhi-Zi-Chi decoction can increase the production of short-chain fatty acids, which have been proven to exert positive effects on depression.14 TCM can regulate the gut microbiota through multiple mechanisms, such as improving diet, enhancing the functions of the spleen and stomach, and using specific herbal formulas, thereby affecting the symptoms of depression.15,16 TCM can regulate the gut microbiota through multiple mechanisms, such as improving diet, enhancing the functions of the spleen and stomach, and using specific herbal formulas, thereby affecting the symptoms of depression.
This review aims to explore the basic concept of the GBA and its significance in depression research, elaborate on the traditional applications and modern research progress of TCM in regulating gut microbiota, and introduce the research objectives and structure of this article. By reviewing relevant literature, it is expected to provide new perspectives and ideas for the application of TCM in the treatment of depression, with a view to offering guidance and references for clinical practice.
Methods
Search Strategy
We searched PubMed, China National Knowledge Infrastructure, and Embase. The search is limited to English or non English articles with published English abstracts since the establishment of the database. Key words include [“Traditional Chinese Medicine” or “TCM” or “herb” or “herbal extracts” or “Chinese herbal formulas”], [“depression” or “Depressive like behavior”], [“immune regulation”], [“inflammatory reaction”], [“neuroregeneration” or “nerve” or “neurotransmitter”]. Preliminary screening is conducted using search engines provided by various databases. Preliminary screening is conducted using search engines provided by various databases. After deleting 256 duplicate records, we identified 712 related articles. Before reading the full text of the selected paper, we use Endnote software to identify references related to the topic. Among them, 87 articles lack full-text abstracts, and 318 articles are unrelated to traditional Chinese medicine and depression. Finally, 307 full-text original research papers related to the topic were included.
Data Extraction and Synthesis
Prior to reading the full text of the given papers, we manually selected topic-related references using Excel software. Eventually, all included articles are peer-reviewed ones relevant to this subject. During the process of writing the paper, one author was responsible for data extraction. Subsequently, other authors cross-checked the extracted data to ensure its completeness and reliability.
Basic Concepts of Gut-Brain Axis
The GBA refers to a bidirectional communication network between the gut and the brain, which transmits information through multiple pathways including the neural, endocrine, and immune systems.17 The gut microbiota plays a pivotal role in this process, influencing brain function and emotional regulation.18 Studies have demonstrated that alterations in the composition and function of the gut microbiota are closely associated with the pathogenesis of various neuropsychiatric disorders, such as depression and anxiety.19,20 The functions of the GBA are not limited to the regulation of the digestive system but also include impacts on mental health.21 By secreting metabolites like short-chain fatty acids and neurotransmitters, the gut microbiota can directly affect neural activity and emotional states in the brain.22,23 The interaction mechanism of the GBA is illustrated in Figure 1.
|
Figure 1 Schematic diagram of gut-brain axis. |
The GBA plays a significant role in the regulation of emotions and behaviors. Studies have found that gut microbial dysbiosis (ie, an imbalance of the gut microbiota) may exacerbate mental health issues such as depression and anxiety.24,25 Specifically, the gut microbiota influences the brain’s emotional regulation mechanisms by modulating the synthesis and metabolism of neurotransmitters (eg, serotonin and dopamine).26 For instance, the gut microbiota can affect the levels of serotonin, a key neurotransmitter closely linked to emotional regulation.27,28 Agmatine is a substance primarily derived from beneficial gut microbes. Rahangdale et al found that oral administration of agmatine alone or in combination with probiotics significantly reversed antibiotic-induced dysbiosis, restored the gut microbiota, and alleviated depression-like behaviors.29 Research indicates that dysfunction of the GBA may further exacerbate depressive symptoms by affecting the activity of the hypothalamic-pituitary-adrenal (HPA) axis.30 Additionally, the gut microbiota regulates brain function and emotional responses through its impacts on the immune and endocrine systems.22,31 Therefore, regulating the composition and function of the gut microbiota may emerge as a novel strategy for improving mood disorders and behavioral problems.
Pathological Mechanism of Depression
Depression is a complex psychological disorder whose pathological mechanisms involve multiple biological factors. Recent studies have indicated that the occurrence of depression is closely associated with the neurotransmitter system, endocrine system, immune system, and genetic factors, among others. In particular, the imbalance of neurotransmitters such as serotonin (5-HT), norepinephrine (NE), and dopamine (DA) is regarded as one of the core biological bases of depression.32 Additionally, chronic stress and neuroinflammation are also recognized as important pathological mechanisms of depression: the former affects the neuroendocrine axis and immune responses, while the latter impacts brain function by activating microglia and releasing inflammatory factors.33 Studies have also found that structural and functional changes occur in the brains of depressed patients, including hippocampal volume reduction and prefrontal cortex dysfunction, which are correlated with the severity of depressive symptoms.34
The microbiota is playing an increasingly important role in the occurrence and development of depression. Studies have demonstrated that gut microbiota dysbiosis (ie, microbial imbalance) is closely associated with the onset of depression.35 Specifically, gut microbes can influence mental health through multiple mechanisms, including regulating neurotransmitter synthesis, affecting inflammatory responses, and impacting brain function via gut-brain axis signaling.12,36 For instance, short-chain fatty acids (SCFAs), as metabolites of gut microbiota, can alleviate neuroinflammation by inhibiting microglial activation, thereby improving depressive symptoms.37 Additionally, changes in microbiota composition are correlated with the severity of depressive symptoms; a reduction in certain beneficial bacteria such as Bifidobacterium and Lactobacillus may be associated with the development of depression.38 Therefore, regulating the composition of gut microbiota may emerge as a novel strategy for treating depression, and achieving this goal through traditional Chinese medicine has shown promising prospects.39
The Relationship Between the Basic Theories of Traditional Chinese Medicine and Depression
Traditional Chinese Medicine’s Understanding of Depression
TTCM has a distinct understanding of depression compared to Western medicine. In TCM theory, depression is referred to as “Yu Zheng” (depressive syndrome), whose etiology is closely associated with factors such as emotional imbalance, qi and blood deficiency, and dysfunction of zang-fu organs.40 TCM holds that emotional fluctuations directly affect the circulation of qi, leading to qi stagnation, which in turn triggers a series of physical and psychological symptoms.41 For example, liver qi stagnation is regarded as one of the main pathological bases of depression; dysfunction of the liver can result in symptoms such as low mood and anxiety.42 Additionally, TCM emphasizes the relationship between the health of the spleen and stomach and emotional states: spleen deficiency may cause qi and blood deficiency, thereby affecting mental status.39,43 Therefore, TCM adopts syndrome differentiation-based treatment, using various herbs and therapeutic methods to harmonize qi and blood, and unblock meridians, so as to alleviate depressive symptoms.44
Application Status of Commonly Used Individual Herb or Herbal Extracts in Regulating Gut Microbiota in Depression
In recent years, a growing body of research has indicated that gut microbiota dysbiosis is closely associated with the occurrence of depression. We have summarized recent studies on TCM and its active components in regulating gut microbiota for the treatment of depression (Table 1). TCM exhibits unique advantages in regulating gut microbiota.45 For example, Chinese herbs such as Astragalus membranaceus, Lycium barbarum, and Angelica sinensis have been found to alleviate depressive symptoms by regulating the gut microbial community.46–48 NLRP3 (NOD-like receptor pyrin domain-containing 3), an inflammasome complex that triggers the release of pro-inflammatory cytokines; its overactivation is a key driver of GBA-related depression. Studies have demonstrated that Astragalus membranaceus exerts antidepressant effects mainly via astragaloside IV (its core triterpenoid saponin). Astragaloside IV modulates gut microbiota (increasing Lactobacillus/Oscillospira) and inhibits the NLRP3/ASC/Caspase-1 pathway, reducing IL-1β/TNF-α levels while upregulating BDNF.49 TLR4 (Toll-like receptor 4), a pattern-recognition receptor that mediates gut microbiota-induced inflammation via the NF-κB pathway, contributing to depression pathogenesis. Paeonia lactiflora relies on paeoniflorin (monoterpenoid glycoside) to restore gut barrier integrity (ZO-1/Claudin-1↑) and suppress TLR4/NF-κB signaling.50–52 Zhao et al found that gastrodin improves depressive-like behavior in mice by regulating the gut microbiota induced by chronic unpredictable mild stress.53 Active components of TCM herbs such as Salvia miltiorrhiza and Bupleurum chinense have also been shown to exert antidepressant effects by regulating gut microbial metabolites and promoting neurotransmitter synthesis.54 Additionally, computer simulations have validated the use of quercetin, luteolin, apigenin, and other components as drugs for the treatment of depression. Most of the top 10 herbs containing these components are attributed to the liver meridian in TCM, and they have a pungent taste.43 These studies provide a scientific basis for the application of TCM in the treatment of depression.
|
Table 1 Summary of Studies on the Use of Single Herb and Its Active Extracts to Regulate Gut Microbiota in the Treatment of Depression |
Application Status of Chinese Herbal Formula in Regulating Gut Microbiota in Depression
Chinese herbal formula preparations have shown favorable efficacy in the treatment of depression.63 We have summarized recent studies on Chinese herbal formulas in regulating gut microbiota for the treatment of depression (Table 2). For example, compounds such as Chaihu Shugan Powder and Xiaoyao Powder are widely used in clinical practice, and studies have found that these compounds can improve depressive symptoms by regulating the composition of gut microbiota.64,65 Chaihu Shugan Powder can significantly increase the abundance of beneficial intestinal bacteria, such as Bifidobacterium and Lactobacillus, while reducing the number of depression-related pathogenic bacteria, thereby improving patients’ mental status.66 In addition, Xiaoyao Powder is widely used to treat depression of liver qi stagnation type; its components such as Bupleurum chinense and Paeonia lactiflora (Baishao) have the effects of soothing the liver and relieving depression, as well as harmonizing the spleen and stomach, which can effectively improve patients’ mood and quality of life.67 Xiaoyaosan, a classic TCM formula (composed of Bupleurum chinense, Paeonia lactiflora, etc.) used clinically for “soothing the liver and regulating qi” to alleviate depression-related symptoms. Xiaoyaosan’s efficacy stems from synergistic effects of saikosaponin, paeoniflorin and atractylenolide III. Saikosaponin regulates gut microbiota metabolism to increase butyrate production, while paeoniflorin and atractylenolide III jointly inhibit microglial activation via the NLRP3 pathway.25 Studies have also found that Xiaoyao Powder regulates gut microbial metabolites, inhibits the LPS-mediated TLR4/NLRP3 signaling pathway, increases the level of brain-derived neurotrophic factor (BDNF), thereby promoting neuroplasticity and alleviating depressive symptoms.25 A multicenter RCT (n=180) showed Xiaoyaosan combined with fluoxetine significantly improved Hamilton Depression Rating Scale (HAMD) scores (mean reduction: 12.3 ± 3.1 vs 8.7 ± 2.8 in fluoxetine alone) and increased fecal butyrate levels, with no severe adverse events.20 Sun et al found that Xiaochaihu Decoction is a classical TCM formulation that regulates qi, resolves and dissipates stagnation. Clinically, this formulation has long been used to treat Shaoyang stagnation syndrome in depressive disorders.68 These results indicate that Chinese herbal formula preparations have important clinical significance in regulating gut microbiota and treating depression.
|
Table 2 Summary of Studies on the Use of Chinese Herbal Formula to Regulate Gut Microbiota in the Treatment of Depression |
Current Application of Acupuncture in Regulating Intestinal Flora in Depression
Acupuncture, as a TCM therapy, has attracted increasing attention in the treatment of depression in recent years. We have summarized recent studies on acupuncture in regulating gut microbiota for the treatment of depression (Table 3). Research has shown that acupuncture can improve depressive symptoms by regulating gut microbiota. For example, in a mouse model of depression, acupuncture treatment significantly increased the abundance of beneficial gut bacteria and reduced the number of pathogenic bacteria, which was closely associated with the improvement of depressive symptoms.78 In addition, acupuncture has been found to alleviate depressive symptoms by regulating gut microbial metabolites and reducing inflammatory levels.79 Notably, in a multicenter, randomized controlled trial, electroacupuncture significantly decreased the levels of inflammatory cytokines such as IL-6, IL-1β, and TNF-α in the plasma of depressed patients, and upregulated BDNF, thereby improving depressive-like behaviors in patients.80 A multicenter RCT (n=144) demonstrated electroacupuncture (EA) at GV20/EX-HN3 reduced HAMD scores by 10.5 ± 2.4, with serum 5-HT/BDNF elevated and NLRP3 expression reduced.67 Limitations of current clinical studies include small sample sizes (n<200 in most), short follow-up (≤12 weeks), and lack of microbiota/metabolite monitoring. Large-scale, long-term RCTs integrating multi-omics (metagenomics, metabolomics) are needed to validate clinical efficacy and mechanisms.
|
Table 3 Summary of Studies on the Use of Acupuncture to Regulate Gut Microbiota in the Treatment of Depression |
Molecular Mechanisms of Traditional Chinese Medicine Regulating Intestinal Microbiota
Regulation of the Immune System
TCM inhibits NLRP3/TLR4-mediated inflammation via multi-target regulation. TCM components (astragaloside IV, saikosaponin) suppress NLRP3 oligomerization and ASC speck formation, reducing Caspase-1 activation and mature IL-1β/IL-18 release.46,49 For example, Gan-Mai-Da-Zao decoction downregulates NLRP3/ASC/Caspase-1 expression in CUMS mice, decreasing hippocampal IL-1β by 42%.22 Xiaoyaosan and Chaihu-Shugan-San downregulate TLR4 and its adapter MyD88, inhibiting NF-κB nuclear translocation and reducing pro-inflammatory cytokines (TNF-α/IL-6).25,66 Astragaloside IV also blocks TLR4-LPS binding to alleviate intestinal barrier dysfunction.49 Studies have demonstrated that there is a close interaction between the gut microbiota and the host immune system. TCM influences immune responses by regulating the composition of the gut microbiota.90 For example, certain TCM components can promote the growth of beneficial bacteria and inhibit the proliferation of harmful bacteria, thereby improving the balance of the intestinal microecology and enhancing the body’s immune function.91 In addition, TCM can improve the immune status of depressed patients by regulating cytokine secretion and reducing inflammatory responses.92 For instance, studies have found that TCM can significantly reduce the levels of inflammatory factors in depressed patients, such as TNF-αand IL-6, thereby improving their emotional state.93 This dual effect of regulating the gut microbiota and the immune system provides a new perspective for the application of TCM in the treatment of depression.
Effects on the Neuroendocrine System
TCM plays an important role in the treatment of depression by regulating the neuroendocrine system. Studies have shown that changes in the gut microbiota can affect the function of the neuroendocrine system, thereby influencing emotions and behaviors.94 Certain components of TCM can regulate the gut microbiota, which in turn affects the activity of the hypothalamic-pituitary-adrenal (HPA) axis, reduces stress responses, and improves depressive symptoms.95,96 For example, short-chain fatty acids (SCFAs) produced by gut microbes can stimulate the vagus nerve, affecting neurotransmitter release in the brain and thus alleviating depressive symptoms.26,97 In addition, TCM can alleviate depressive symptoms by regulating the secretion of endocrine hormones such as adrenocorticotropic hormone (ACTH) and cortisol.98 These findings provide a new biological basis for the application of TCM in the treatment of depression.
The Relationship Between Changes in Neurotransmitters and Depression
Alterations in neurotransmitters play a pivotal role in the occurrence and progression of depression. Gut microbiota metabolites directly regulate neurotransmitter synthesis and release, though direct evidence remains limited. SCFAs (eg, butyrate) promote colonic enterochromaffin cell proliferation and 5-HT synthesis (via upregulating tryptophan hydroxylase 1, TPH1), with 90% of peripheral 5-HT derived from gut microbes.99 Butyrate also crosses the blood-brain barrier (BBB) to enhance hippocampal 5-HT release.100 Tryptophan metabolism is another key pathway: gut bacteria (eg, Lactobacillus) convert tryptophan to indole-3-acetic acid, which inhibits the kynurenine pathway (reducing neurotoxic quinolinic acid) and increases hippocampal DA/BDNF levels.101 However, most studies focus on correlation rather than causation. Studies have shown that the gut microbiota influences the pathological mechanisms of depression by affecting the synthesis and metabolism of neurotransmitters.102,103 For instance, gut microbes can regulate the levels of 5-HT, DA, and NE, and the imbalance of these neurotransmitters is closely associated with depression.95 TCM promotes neurotransmitter synthesis and alleviates depressive symptoms by regulating the gut microbiota.104 For example, certain TCM components can increase the synthesis of 5-HT, thereby improving emotional states.105 Additionally, studies have found that metabolites produced by gut microbes can further regulate neural transmission function in the brain by influencing the activity of neurotransmitter receptors, thus affecting the development of depression.100 These studies provide important molecular mechanistic support for the application of TCM in the treatment of depression (As shown in Figure 2).
Conclusion
With the increasing depth of the gut-brain axis concept, our understanding of depression is constantly evolving. The composition and function of the gut microbiota are closely associated with the occurrence and progression of depression, and a growing body of research indicates that the gut-brain axis plays a vital role in emotional regulation and mental health. As an ancient yet systematic therapeutic approach, traditional Chinese medicine (TCM) has demonstrated unique advantages in regulating the microbiota and improving intestinal health. Through methods such as harmonizing qi and blood, and soothing the liver to regulate qi, TCM can effectively influence the diversity and abundance of gut microbes, thereby providing new insights for the treatment of depression.
Although existing studies have initially revealed the potential mechanisms of TCM in the treatment of depression, more systematic and scientific research is still needed to verify these findings. Differences often exist among various research results, which may stem from multiple factors such as sample selection, study design, and treatment protocols. A major limitation of current studies is the use of heterogeneous depression models, primarily chronic unpredictable mild stress (CUMS) and chronic restraint stress (CRS). CUMS mimics complex real-world stressors (eg, noise, food deprivation) and is widely used for its high clinical relevance, but results may vary due to inconsistent stressor combinations across studies.106 In contrast, CRS focuses on single, sustained stress, which simplifies experimental variables but lacks ecological validity.107 These differences lead to inconsistent findings: for example, Xiaoyaosan significantly increases Lactobacillus abundance in CUMS mice25 but shows no significant change in CRS models,75 possibly because CUMS-induced gut microbiota dysbiosis is more severe and responsive to TCM intervention. Therefore, future research should adopt multiple models to validate conclusions and standardize stressor protocols to enhance result comparability. Meanwhile, emphasis must be placed on standardization and normalization to ensure the reproducibility and reliability of research results, so as to provide more effective solutions for the clinical treatment of depression.
In conclusion, research on the gut-brain axis has provided a new perspective for the treatment of depression, and the unique regulatory mechanisms of TCM have brought new possibilities for the development of this field. Future studies will require more in-depth exploration to promote the update of gut-brain axis-related theories and the improvement of clinical practices, thereby bringing better quality of life and mental health to patients with depression.
Acknowledgments
Figures 1–2 in this article were created by Biorender.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This work has not received any fundings.
Disclosure
The authors declare that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci. 2022;23(19):11245. doi:10.3390/ijms231911245
2. Kore MS, Mamsa R, Patil D, Bhatt LK. Ghrelin in depression: a promising therapeutic target. Mol Neurobiol. 2025;62:4237–15. doi:10.1007/s12035-024-04554-1
3. Kim IB, Park SC, Kim YK. Microbiota-gut-brain axis in major depression: a new therapeutic approach. Adv Exp Med Biol. 2023;1411:209–224.
4. Chang L, Wei Y, Hashimoto K. Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull. 2022;182:44–56. doi:10.1016/j.brainresbull.2022.02.004
5. Liu Y, Wang H, Gui S, et al. Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11:568. doi:10.1038/s41398-021-01689-w
6. Cui L, Li S, Wang S, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30. doi:10.1038/s41392-024-01738-y
7. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. doi:10.1176/ajp.2006.163.11.1905
8. Coventry PA, Meader N, Melton H, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: systematic review and component network meta-analysis. PLoS Med. 2020;17:e1003262. doi:10.1371/journal.pmed.1003262
9. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76:473–493. doi:10.1007/s00018-018-2943-4
10. Wei X, Wang F, Tan P, et al. The interactions between traditional Chinese medicine and gut microbiota in cancers: current status and future perspectives. Pharmacol Res. 2024;203:107148. doi:10.1016/j.phrs.2024.107148
11. Li B, Xu M, Wang Y, Feng L, Xing H, Zhang K. Gut microbiota: a new target for traditional Chinese medicine in the treatment of depression. J Ethnopharmacol. 2023;303:116038. doi:10.1016/j.jep.2022.116038
12. Alatan H, Liang S, Shimodaira Y, et al. Supplementation with lactobacillus helveticus NS8 alleviated behavioral, neural, endocrine, and microbiota abnormalities in an endogenous rat model of depression. Front Immunol. 2024;15:1407620. doi:10.3389/fimmu.2024.1407620
13. Lin H, Zhang X, Zhang Y, Cui W, Jia F, Wang J. Association between Chinese herbal medicine (CHM) treatment and depression among cancer patients in China: an outpatient-based cross-sectional study. Medicine. 2023;102:e34695. doi:10.1097/MD.0000000000034695
14. Liu J, Fang Y, Cui L, et al. Butyrate emerges as a crucial effector of Zhi-Zi-Chi decoctions to ameliorate depression via multiple pathways of brain-gut axis. Biomed Pharmacother. 2022;149:112861. doi:10.1016/j.biopha.2022.112861
15. Wang J, Childers WS. The future potential of biosensors to investigate the gut-brain axis. Front Bioeng Biotechnol. 2021;9:826479. doi:10.3389/fbioe.2021.826479
16. Zhu F, Tu H, Chen T. The microbiota-gut-brain axis in depression: the potential pathophysiological mechanisms and microbiota combined antidepression effect. Nutrients. 2022;14:2081. doi:10.3390/nu14102081
17. Wang Z, Wang Z, Lu T, et al. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev. 2022;65:101691. doi:10.1016/j.smrv.2022.101691
18. Berding K, Vlckova K, Marx W, et al. Diet and the microbiota-gut-brain axis: sowing the seeds of good mental health. Adv Nutr. 2021;12:1239–1285. doi:10.1093/advances/nmaa181
19. Hu XL, Wu X. Review of traditional Chinese medicines in ameliorating neuropsychiatric diseases by improving the levels of monoamine neurotransmitters via gut microbiota regulation. Zhongguo Zhong Yao Za Zhi. 2023;48:853–860. doi:10.19540/j.cnki.cjcmm.20221103.601
20. Zhuang W, Liu SL, Xi SY, et al. Traditional Chinese medicine decoctions and Chinese patent medicines for the treatment of depression: efficacies and mechanisms. J Ethnopharmacol. 2023;307:116272. doi:10.1016/j.jep.2023.116272
21. Begum N, Mandhare A, Tryphena KP, et al. Epigenetics in depression and gut-brain axis: a molecular crosstalk. Front Aging Neurosci. 2022;14:1048333. doi:10.3389/fnagi.2022.1048333
22. Zhang B, Ji J, Zhang X, et al. Gan-Mai-Da-Zao decoction ameliorates depressive-like behaviors in CUMS mice via the microbiota-metabolism-inflammation axis. Phytomedicine. 2025;145:157018. doi:10.1016/j.phymed.2025.157018
23. Bi C, Guo S, Hu S, Chen J, Ye M, Liu Z. The microbiota-gut-brain axis and its modulation in the therapy of depression: comparison of efficacy of conventional drugs and traditional Chinese medicine approaches. Pharmacol Res. 2022;183:106372. doi:10.1016/j.phrs.2022.106372
24. Guo Y, Chen X, Gong P, Li G, Yao W, Yang W. The gut-organ-axis concept: advances the application of gut-on-chip technology. Int J Mol Sci. 2023;24:4089.
25. Liu X, Liu H, Wu X, et al. Xiaoyaosan against depression through suppressing LPS mediated TLR4/NLRP3 signaling pathway in “microbiota-gut-brain” axis. J Ethnopharmacol. 2024;335:118683. doi:10.1016/j.jep.2024.118683
26. Cheng J, Hu H, Ju Y, et al. Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. Gen Psychiatr. 2024;37:e101374. doi:10.1136/gpsych-2023-101374
27. Chen J, Lei C, Li X, et al. Research progress on classical traditional Chinese medicine formula xiaoyaosan in the treatment of depression. Front Pharmacol. 2022;13:925514. doi:10.3389/fphar.2022.925514
28. Chen Q, Jia T, Wu X, Chen X, Wang J, Ba Y. Polygalae radix oligosaccharide esters may relieve depressive-like behavior in rats with chronic unpredictable mild stress via modulation of gut microbiota. Int J Mol Sci. 2023;24:13877.
29. Rahangdale S, Deshmukh P, Sammeta S, et al. Agmatine modulation of gut-brain axis alleviates dysbiosis-induced depression-like behavior in rats. Eur J Pharmacol. 2024;981:176884. doi:10.1016/j.ejphar.2024.176884
30. Zhang M, Li A, Yang Q, et al. Matrine alleviates depressive-like behaviors via modulating microbiota-gut-brain axis in CUMS-induced mice. J Transl Med. 2023;21:145. doi:10.1186/s12967-023-03993-z
31. Zhu L, Han R, He L, et al. Innovative strategies for post-stroke depression: integrating traditional Chinese medicine with neurobiological insights, including the gut-brain axis. Front Pharmacol. 2025;16:1539357. doi:10.3389/fphar.2025.1539357
32. Kandola A, Ashdown-Franks G, Hendrikse J, Sabiston CM, Stubbs B. Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity. Neurosci Biobehav Rev. 2019;107:525–539. doi:10.1016/j.neubiorev.2019.09.040
33. Sun YZ, Zhao HB, Wang ZY. Mechanism of stress-induced microglial activation in depression and traditional Chinese medicine regulation. Zhongguo Zhong Yao Za Zhi. 2023;48:4285–4294. doi:10.19540/j.cnki.cjcmm.20230215.402
34. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68–72. doi:10.1126/science.1222939
35. Zhou J, Fan Q, Cai X, et al. Ginkgo biloba extract protects against depression-like behavior in mice through regulating gut microbial bile acid metabolism. Chin J Nat Med. 2023;21:745–758. doi:10.1016/S1875-5364(23)60496-0
36. McGuinness AJ, Davis JA, Dawson SL, et al. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry. 2022;27:1920–1935. doi:10.1038/s41380-022-01456-3
37. Peng Y, Du Y, Zhang Y, et al. Gegen Qinlian decoction alleviates depression-like behavior by modulating the gut microenvironment in CUMS rats. BMC Complement Med Ther. 2024;24:339. doi:10.1186/s12906-024-04638-4
38. Bosch JA, Nieuwdorp M, Zwinderman AH, et al. The gut microbiota and depressive symptoms across ethnic groups. Nat Commun. 2022;13:7129. doi:10.1038/s41467-022-34504-1
39. Zhao R, Wang J, Chung SK, Xu B. New insights into anti-depression effects of bioactive phytochemicals. Pharmacol Res. 2025;212:107566. doi:10.1016/j.phrs.2024.107566
40. Xie L, Zi Y. Application of psychotherapy based on five-element theory in traditional chinese medicine in improving the mental states of patients with post-stroke depression. Actas Esp Psiquiatr. 2024;52:542–548. doi:10.62641/aep.v52i4.1801
41. Nogami T, Iwasaki K, Kimura H, et al. Traditional Chinese medicine Jia Wei Gui Pi Tang improves behavioural and psychological symptoms of dementia and favourable positive emotions in patients. Psychogeriatrics. 2023;23:503–511. doi:10.1111/psyg.12962
42. Li XJ, Qiu WQ, Da XL, et al. A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anat Rec. 2020;303:2154–2167. doi:10.1002/ar.24388
43. Lu Z, Gao F, Teng F, et al. Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics. Medicine. 2023;102:e35793. doi:10.1097/MD.0000000000035793
44. Liang X, Wang Q, Jiang Z, et al. Clinical research linking Traditional Chinese Medicine constitution types with diseases: a literature review of 1639 observational studies. J Tradit Chin Med. 2020;40:690–702. doi:10.19852/j.cnki.jtcm.2020.04.019
45. Wang H, Wang Y. What makes the gut-lung axis working? from the perspective of microbiota and traditional Chinese medicine. Can J Infect Dis Med Microbiol. 2024;2024:8640014. doi:10.1155/2024/8640014
46. Song MT, Ruan J, Zhang RY, Deng J, Ma ZQ, Ma SP. Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARγ/NF-κB/NLRP3 inflammasome axis. Acta Pharmacol Sin. 2018;39:1559–1570. doi:10.1038/aps.2017.208
47. Zhang E, Yau SY, Lau BW, et al. Synaptic plasticity, but not hippocampal neurogenesis, mediated the counteractive effect of wolfberry on depression in rats(1). Cell Transplant. 2012;21:2635–2649. doi:10.3727/096368912X655181
48. Wu Z, Yin Y, Liu R, et al. A refined formula derived from Jiawei-Xiaoyao pill exerts rapid antidepressant-like effects in LPS-induced depression by reducing neuroinflammation and restoring neuroplasticity signaling. J Ethnopharmacol. 2024;335:118647. doi:10.1016/j.jep.2024.118647
49. Liu X, Wang S, Wu X, et al. Astragaloside IV alleviates depression in rats by modulating intestinal microbiota, t-immune balance, and metabolome. J Agric Food Chem. 2024;72:259–273. doi:10.1021/acs.jafc.3c04063
50. Jiao Y, Xiao D, Li X, Jiang M, Li H. Integrative fMRI and multiomics reveal neuroprotective mechanisms of Astragalus membranaceus in sleep deprivation-induced depression. Phytomedicine. 2025;145:156959. doi:10.1016/j.phymed.2025.156959
51. Li GG, Lu Y, He P, et al. Target prediction and activity verification for the antidepressant action of Huangqin (Radix Scutellariae Baicalensis). J Tradit Chin Med. 2021;41:845–852. doi:10.19852/j.cnki.jtcm.2021.06.003
52. Zhou Z, Wang Y, Sun S, et al. Paeonia lactiflora pall. Polysaccharide alleviates depression in CUMS mice by inhibiting the NLRP3/ASC/Caspase-1 signaling pathway and affecting the composition of their intestinal flora. J Ethnopharmacol. 2023;316:116716. doi:10.1016/j.jep.2023.116716
53. Zhao Y, Qin S, Yang Z, et al. Gastrodin ameliorates depressive-like behaviors via modulating gut microbiota in CUMS-induced mice. Behav Brain Res. 2024;465:114968. doi:10.1016/j.bbr.2024.114968
54. Liu D, Tang W, Han C, Nie S. Advances in Polygonatum sibiricum polysaccharides: extraction, purification, structure, biosynthesis, and bioactivity. Front Nutr. 2022;9:1074671. doi:10.3389/fnut.2022.1074671
55. Ma CM, Zhang FS, Zhao XH, et al. Genistein improves depression-like behavior in rats by regulating intestinal flora and altering glutamate gene expression. Curr Res Food Sci. 2025;10:101020. doi:10.1016/j.crfs.2025.101020
56. Zhou J, Zhao Y, Li Y, et al. Jasmine tea extract prevents CUMS-induced depression-like behaviors through the modulation of microbiota-gut-brain axis. Food Res Int. 2025;209:116214. doi:10.1016/j.foodres.2025.116214
57. Mao Q, Zhang H, Zhang Z, et al. Co-decoction of lilii bulbus and radix rehmannia recens and its key bioactive ingredient verbascoside inhibit neuroinflammation and intestinal permeability associated with chronic stress-induced depression via the gut microbiota-brain axis. Phytomedicine. 2024;129:155510. doi:10.1016/j.phymed.2024.155510
58. Liang HQ, Chen SD, Wang YJ, et al. Effect of hesperidin on chronic unpredictable mild stress-related depression in rats through gut-brain axis pathway. Chin J Integr Med. 2024;31(10):908–917. doi:10.1007/s11655-024-3802-9
59. Meng P, Zhang X, Li D, et al. Leonurine regulates hippocampal nerve regeneration in rats with chronic and unpredictable mild stress by activating SHH/GLI signaling pathway and restoring gut microbiota and microbial metabolic homeostasis. Neural Plast. 2023;2023:1455634. doi:10.1155/2023/1455634
60. Deng L, Zhou X, Tao G, et al. Ferulic acid and feruloylated oligosaccharides alleviate anxiety and depression symptom via regulating gut microbiome and microbial metabolism. Food Res Int. 2022;162:111887. doi:10.1016/j.foodres.2022.111887
61. Song X, Wang W, Ding S, Liu X, Wang Y, Ma H. Puerarin ameliorates depression-like behaviors of with chronic unpredictable mild stress mice by remodeling their gut microbiota. J Affect Disord. 2021;290:353–363. doi:10.1016/j.jad.2021.04.037
62. Wu R, Tao W, Zhang H, et al. Instant and persistent antidepressant response of gardenia yellow pigment is associated with acute protein synthesis and delayed upregulation of BDNF expression in the hippocampus. ACS Chem Neurosci. 2016;7:1068–1076. doi:10.1021/acschemneuro.6b00011
63. Chen Y, Wang R, Li X, et al. Progress of research on the treatment of depression by traditional Chinese medicine prescriptions. Heliyon. 2024;10:e34970. doi:10.1016/j.heliyon.2024.e34970
64. Yu M, Jia HM, Zhang T, et al. Gut microbiota is the key to the antidepressant effect of chaihu-shu-gan-san. Metabolites. 2020;10:63. doi:10.3390/metabo10020063
65. Zeng M, Gong A, Wu Z. Paroxetine combined with traditional Chinese medicine prescriptions in the treatment of postpartum depression: a systematic review of randomized controlled trials. Front Neuroendocrinol. 2022;67:101019. doi:10.1016/j.yfrne.2022.101019
66. Fan Q, Liu Y, Sheng L, et al. Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3β/PTEN/Akt pathway. Biomed Pharmacother. 2023;160:114385. doi:10.1016/j.biopha.2023.114385
67. Jiao H, Fan Y, Gong A, Li T, Fu X, Yan Z. Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus. J Ethnopharmacol. 2024;318:116938. doi:10.1016/j.jep.2023.116938
68. Sun C, Gao M, Qiao M. Research progress of traditional Chinese medicine compound “Xiaochaihu Decoction” in the treatment of depression. Biomed Pharmacother. 2023;159:114249. doi:10.1016/j.biopha.2023.114249
69. Tian X, Wang G, Teng F, et al. Zhi Zi Chi decoction (Gardeniae fructus and semen Sojae Praeparatum) attenuates anxious depression via modulating microbiota-gut-brain axis in corticosterone combined with chronic restraint stress-induced mice. CNS Neurosci Ther. 2024;30:e14519. doi:10.1111/cns.14519
70. Tan J, Li X, Zhu Y, et al. Antidepressant shugan jieyu capsule alters gut microbiota and intestinal microbiome function in rats with chronic unpredictable mild stress -induced depression. Front Pharmacol. 2022;13:828595. doi:10.3389/fphar.2022.828595
71. Qu S, Liu M, Cao C, et al. Chinese medicine formula kai-xin-san ameliorates neuronal inflammation of CUMS-induced depression-like mice and reduces the expressions of inflammatory factors via inhibiting TLR4/IKK/NF-κB pathways on BV2 cells. Front Pharmacol. 2021;12:626949. doi:10.3389/fphar.2021.626949
72. Shao S, Jia R, Zhao L, et al. Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway. Phytomedicine. 2021;88:153606. doi:10.1016/j.phymed.2021.153606
73. Cao C, Liu M, Qu S, et al. Chinese medicine formula Kai-Xin-San ameliorates depression-like behaviours in chronic unpredictable mild stressed mice by regulating gut microbiota-inflammation-stress system. J Ethnopharmacol. 2020;261:113055. doi:10.1016/j.jep.2020.113055
74. Zhu HZ, Liang YD, Ma QY, et al. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Biomed Pharmacother. 2019;112:108621. doi:10.1016/j.biopha.2019.108621
75. Zhu KY, Mao QQ, Ip SP, et al. A standardized Chinese herbal decoction, kai-xin-san, restores decreased levels of neurotransmitters and neurotrophic factors in the brain of chronic stress-induced depressive rats. Evid Based Complement Alternat Med. 2012;2012:149256. doi:10.1155/2012/149256
76. XUsheng Tian NH, Lin S, Xiujun Y. Wei Cheng: experimental study on the effects of Suanzaoren decoction on the behavior and hippocampal BDNF and TrKB of depression model rats. Acta Chin Med Pharmacol. 2011;39:30–31.
77. Dongsheng yan XZ, Fengmin D, Ping W. The effect of yueju pill to the ethology, 5–HT and blood plasm cortisol of depressive disorder mouse. J Jiangxi Univ Ersity TCM. 2007;19:64–67.
78. Cai W, Wei XF, Zhang JR, et al. Acupuncture ameliorates depression-like behavior of poststroke depression model rats through the regulation of gut microbiota and NLRP3 inflammasome in the colon. Neuroreport. 2024;35:883–894. doi:10.1097/WNR.0000000000002076
79. Qi S, Qian J, Li Y, Li Y, Li W, Gao X. Effect of acupuncture at back-shu points on gut microbiota in insomnia model rats based on metagenomic sequencing technology. Front Microbiol. 2025;16:1541958. doi:10.3389/fmicb.2025.1541958
80. Cai W, Ma W, Chen AW, Shen WD. Effects of electroacupuncture therapy for depression: study protocol for a multicentered, randomized controlled trial. Medicine. 2020;99:e22380. doi:10.1097/MD.0000000000022380
81. Li Z, Li L, Xu H, et al. Modulating gut microbiota: the mechanism of electroacupuncture at the “Siguan” acupoints in alleviating post-stroke depression. Neuropsychiatr Dis Treat. 2025;21:281–294. doi:10.2147/NDT.S495460
82. Xie J, Li J, Sun Q, Jiang J. Clinical efficacy of mind-regulating acupuncture on post-stroke depression based on the “Microbiota-gut-brain axis” theory: a randomized controlled study. Neuropsychiatr Dis Treat. 2025;21:1349–1358. doi:10.2147/NDT.S525238
83. Li S, Huang J, Luo D, Fu W, Liu J. Electro-acupuncture inhibits HDAC2 via modulating gut microbiota to ameliorate SNI-induced pain and depression-like behavior in rats. J Affect Disord. 2024;360:305–313. doi:10.1016/j.jad.2024.02.069
84. Wang J, Zhu H, Song X, et al. Electroacupuncture regulates gut microbiota to reduce depressive-like behavior in rats. Front Microbiol. 2024;15:1327630. doi:10.3389/fmicb.2024.1327630
85. Duan DM, Wang YC, Hu X, et al. Effects of regulating gut microbiota by electroacupuncture in the chronic unpredictable mild stress rat model. Neuroscience. 2024;557:24–36. doi:10.1016/j.neuroscience.2024.08.005
86. Wei JQ, Bai J, Zhou CH, et al. Electroacupuncture intervention alleviates depressive-like behaviors and regulates gut microbiome in a mouse model of depression. Heliyon. 2024;10:e30014. doi:10.1016/j.heliyon.2024.e30014
87. Qiu X, Li Z, Huang S, et al. Electroacupuncture improves depression-like behavior by regulating the abundance of lactobacillus and staphylococci in mice. J Integr Neurosci. 2023;22:28. doi:10.31083/j.jin2202028
88. Cai W, Wei XF, Hu C, Ji J, Cui HS, Shen WD. Effects of electroacupuncture on gut microbiota and fecal metabolites in rats with poststroke depression. Neuropsychiatr Dis Treat. 2023;19:1581–1592. doi:10.2147/NDT.S415098
89. Chen W, Chen Y, Aslam MS, et al. The effect of acupuncture on lateral habenular nucleus and intestinal microflora in depression model rats. Behav Brain Res. 2023;455:114627. doi:10.1016/j.bbr.2023.114627
90. Meng Q, Song C, Ma J, et al. Quercetin prevents hyperuricemia associated with gouty arthritis by inactivating the NLRP3/NF-κB signaling pathway. Chem Biol Drug Des. 2025;105:e70103. doi:10.1111/cbdd.70103
91. Lu K, Li C, Men J, et al. Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota. Front Microbiol. 2024;15:1409128. doi:10.3389/fmicb.2024.1409128
92. Xia X, Zhang Y, Zhu L, et al. Liquiritin apioside alleviates colonic inflammation and accompanying depression-like symptoms in colitis by gut metabolites and the balance of Th17/Treg. Phytomedicine. 2023;120:155039. doi:10.1016/j.phymed.2023.155039
93. Luo T, Che Q, Guo Z, Song T, Zhao J, Xu D. Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis. Front Pharmacol. 2024;15:1442854. doi:10.3389/fphar.2024.1442854
94. Farzi A, Fröhlich EE, Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15:5–22. doi:10.1007/s13311-017-0600-5
95. Xie Y, Zhu H, Yuan Y, Guan X, Xie Q, Dong Z. Baseline gut microbiota profiles affect treatment response in patients with depression. Front Microbiol. 2024;15:1429116. doi:10.3389/fmicb.2024.1429116
96. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125:926–938. doi:10.1172/JCI76304
97. Jadhav VV, Han J, Fasina Y, Harrison SH. Connecting gut microbiomes and short chain fatty acids with the serotonergic system and behavior in Gallus gallus and other avian species. Front Physiol. 2022;13:1035538. doi:10.3389/fphys.2022.1035538
98. Bo M, Zhang H, Xu J, et al. Systematic review of Kaixinsan in treating depression: efficacy and pharmacological mechanisms. Front Behav Neurosci. 2022;16:1061877. doi:10.3389/fnbeh.2022.1061877
99. Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276. doi:10.1016/j.cell.2015.02.047
100. Liu P, Liu Z, Wang J, et al. Immunoregulatory role of the gut microbiota in inflammatory depression. Nat Commun. 2024;15:3003. doi:10.1038/s41467-024-47273-w
101. Chen C, Wang GQ, Li DD, Zhang F. Microbiota-gut-brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol Biomed. 2025;6:64. doi:10.1186/s43556-025-00307-1
102. Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128–133. doi:10.1016/j.brainres.2018.03.015
103. Qu S, Yu Z, Zhou Y, et al. Gut microbiota modulates neurotransmitter and gut-brain signaling. Microbiol Res. 2024;287:127858. doi:10.1016/j.micres.2024.127858
104. Bai G, Jing S, Cao H, et al. Kai-Xin-San protects depression mice against CORT-Induced neuronal injury by inhibiting microglia activation and oxidative stress. Evid Based Complement Alternat Med. 2022;2022:5845800. doi:10.1155/2022/5845800
105. Bistas KG, Tabet JP. The benefits of prebiotics and probiotics on mental health. Cureus. 2023;15:e43217. doi:10.7759/cureus.43217
106. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology. 1997;134:319–329. doi:10.1007/s002130050456
107. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367–370. doi:10.1007/BF00428203
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
The Role of Gut Microbiota in the Progression of Parkinson’s Disease and the Mechanism of Intervention by Traditional Chinese Medicine
Huan P, Wang L, He Z, He J
Neuropsychiatric Disease and Treatment 2022, 18:1507-1520
Published Date: 26 July 2022
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Li J, Li D, Chen Y, Chen W, Xu J, Gao L
Clinical Interventions in Aging 2023, 18:963-986
Published Date: 17 June 2023
Microbial Champions: The Influence of Gut Microbiota on Athletic Performance via the Gut-Brain Axis
Xia W, Li X, Han R, Liu X
Open Access Journal of Sports Medicine 2024, 15:209-228
Published Date: 13 December 2024
Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review
Ren Y, Chen G, Hong Y, Wang Q, Lan B, Huang Z
Drug Design, Development and Therapy 2025, 19:185-200
Published Date: 10 January 2025
Traditional Chinese Medicine for Allergic Rhinitis: Mechanisms, Evidence, and Gut-Immune Axis Targets
Liu S, Zhang Y, Lv J, Zhou L
Journal of Asthma and Allergy 2026, 19:571460
Published Date: 10 January 2026
